Accès libre

Relationship between chromosomal aberrations and gene expressions in the p53 pathway in chronic lymphocytic leukemia

À propos de cet article

Citez

Figure 1

Scatterplot comparing the normalized expression of genes between the CLL patients and healthy controls. Genes involved in CLL cell cycle and cell growth, proliferation and differentiation and apoptosis are shown. The central line indicates unchanged gene expression. Red dots represent genes with a fold regulation of >2.
Scatterplot comparing the normalized expression of genes between the CLL patients and healthy controls. Genes involved in CLL cell cycle and cell growth, proliferation and differentiation and apoptosis are shown. The central line indicates unchanged gene expression. Red dots represent genes with a fold regulation of >2.

Figure 2

Illustration of interactions between the 18 differentially-expressed genes in CLL patients (String v10, confidence view).
Illustration of interactions between the 18 differentially-expressed genes in CLL patients (String v10, confidence view).

The mean difference values of the patient and control group according to average ᐃCt and fold change.

GeneAverage CtAverage ᐃCt2-ᐃCtFold Changep ValueFold Regulation
CLLControlCLLControlCLLControlCLL/ Control95% CICLL/ Control
APAF126.5725.287.727.540.0046950.0053680.870.78-0.960.072729-1.14
ATM27.8527.919.0110.170.0019360.0008692.231.67-2.79<0.0012.23
ATR29.0029.4110.1711.670.0008710.0003072.832.23-3.43<0.0012.83
BAX25.6125.876.788.130.0091160.0035782.552.15-2.95<0.0012.55
CASP927.3527.588.529.840.0027230.0010912.502.06-2.94<0.0012.50
CDK426.9227.968.0910.220.0036720.0008394.383.20-5.56<0.0014.38
CDKN1A27.5926.828.759.080.0023150.0018521.250.97-1.530.0661.25
CDKN2A30.5032.7711.6715.020.0003070.00003010.227.14-13.3<0.00110.22
CHEK131.3731.5812.5413.830.0001680.0000682.451.98-2.92<0.0012.45
CHEK229.4530.4210.6212.680.0006380.0001524.183.02-5.34<0.0014.18
E2F131.4430.8812.6013.140.0001610.0001111.451.04-1.860.0127411.45
E2F328.8827.0910.059.340.0009440.0015410.610.53-0.69<0.001-1.63
GADD45A31.9431.1413.1013.390.0001140.0000931.220.90-1.540.1211.22
MCL123.3421.854.514.110.0439500.0579650.760.66-0.86<0.001-1.32
MDM225.7725.606.937.860.0081840.0043121.901.56-2.24<0.0011.90
MDM427.4328.008.6010.260.0025770.0008183.152.32-3.998<0.0013.15
PCNA25.7526.366.928.620.0082660.0025453.252.64-3.86<0.0013.25
PTEN25.5324.056.506.310.0110360.0126150.870.78-0.960.062542-1.14
RB126.5127.047.679.290.0048940.0015953.072.40-3.74<0.0013.07
P5325.7626.326.928.580.0082290.0026193.142.47-3.81<0.0013.14
PTX332.5030.5313.6712.790.0000770.0001410.540.37-0.710.006057-1.84
BCL225.9427.947.1110.200.0072310.0008508.5'5.46-11.56<0.0018.51

Patient diagnostic data and FISH results.

nSex-AgePrognosisRai StageBinet StageFISH Results(WBC 109/L)Hb (g/dL)Platelet (109/L)
del(13q)del(17p)+12Normal

Non-del(13q), del(17p), +12.

1F-75bad1B[–][+][–][–]12.612.7166.0
2M-71good0A[–][–][–][+]23.012.0203.0
3M-57good0A[–][–][–][+]24.815.1262.0
4M-56good3A[–][–][–][+]71.413.249.0
5F-59bad2B[–][+][–][–]7.910.9284.0
6F-74bad2B[–][+][–][–]108.610.3190.0
7F-63bad2A[–][+][–][–]35.413.4185.0
8M-80bad2A[–][+][–][–]3.612.9104.0
9F-62bad0A[–][–][+][–]190.212.0192.0
10M-67bad2A[–][–][+][–]142.611.681.0
11F-65bad0A[–][–][+][–]5.212.1144.0
12F-74bad2A[–][–][+][–]179.711.9321.0
13F-86bad3A[–][–][+][–]213.08.6113.0
14M-60good3A[–][–][–][+]51.79.4137.0
15M-46good2A[–][–][–][+]15.014.4184.0
16M-54good0A[–][–][–][+]41.913.8352.0
17F-61good1A[–][–][–][+]11.812.1148.0
18F-67good0A[–][–][–][+]195.310.8188.0
19F-53good2B[–][–][–][+]39.811.4135.0
20M-67good0A[+][–][–][–]74.612.4183.0
21M-62good2A[+][–][–][–]121.414.5294.0
22M-68good0A[+][–][–][–]37.713.9197.0
23F-46good1A[+][–][–][–]59.412.391.0
24M-58good2B[+][–][–][–]201.411.1101.0
25M-66good0A[+][–][–][–]43.912.388.0
26M-61good4C[+][–][–][–]110.013.939.0
27M-51good2A[+][–][–][–]98.514.3250.0
28F-78good3B[+][–][–][–]13.711.0324.0
29F-63good0A[+][–][–][–]113.311.5178.0
30M-64good0A[+][–][–][–]432.015.3206.0
eISSN:
1311-0160
Langue:
Anglais
Périodicité:
2 fois par an
Sujets de la revue:
Medicine, Basic Medical Science, other